Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...

The US Food and Drug Administration (FDA) has granted approval to Akeso's differentiated programmed cell death protein 1 ...

A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

Not letting its expansion efforts idle, contract manufacturer PCI Pharma Services is picking up a 100% stake in Ajinomoto's ...

Headquartered in Pleasanton, California, Boster Biological Technology is making waves in the research community with its ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

The Cancer Biologics Market is witnessing remarkable growth fueled by an expanding therapeutic landscape and a burgeoning pipeline of innovative biologic therapies. Unlike traditional treatments, ...

Creative Diagnostics has announced its highly validated antibodies for tRNA Modification Detection. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading ...